Specialized Care for Skin Conditions, From Common to Rare
Children are aware of their appearance from a very young age. So skin conditions on the face or other parts of the body can affect children's self-esteem, as well as their comfort. At NewYork-Presbyterian, we offer a full range of services for infants, children, and adolescents with all types of skin disorders. We treat common conditions such as acne, atopic dermatitis, hemangiomas, psoriasis, herpes simplex, port wine stains, warts, and skin infections. We also offer expert diagnosis and treatment for children with complex and less common skin diseases such as vascular anomalies, milaria, hidradenitis, impetigo, and genetic skin diseases. We understand that children require a special kind of attention and understanding, and we'll customize a plan of care specific to your child’s developmental and physical needs.
A Team of Experts: Your child's healthcare team has specialized training in dermatology, pediatrics, and pediatric dermatology. We have a compassionate and skilled understanding about how your child’s skin condition affects his or her overall health. Since your child’s skin condition may be complicated and associated with other conditions, we collaborate with other pediatric specialists throughout NewYork-Presbyterian. Together, we do whatever we can to prevent your child's skin disorder from permanently affecting his or her cosmetic appearance.
Specialty Clinics: At our clinics for rare, challenging conditions like epidermolysis bullosa, neurocutaneous disorders, and vascular anomalies, we bring together specialists from many other divisions and departments to create the best treatment plan for your child.
Expert Laser Therapy: We offer laser procedures, in the office or as an outpatient procedure, to treat vascular birthmarks and inflammatory and autoimmune skin disorders.
Cutting-Edge Research: We design and participate in clinical and translational research projects to advance the care of children with skin disorders. Our specialists are members of national research collaborations, including the Hemangioma Investigator Group (HIG) and the Pediatric Dermatology Research Alliance (PeDRA).